How Gene Expression in the First Year After Diagnosis May Help Predict Type 1 Diabetes Progression

Type 1 diabetes affects people differently. Some experience a rapid decline in insulin production after diagnosis, while others maintain some insulin-making capacity for longer. This variability makes it harder to develop treatments and manage the disease effectively for individual patients. If researchers could predict who will progress faster, it might open doors to more tailored treatment approaches.

Scientists analyzed gene expression data—essentially, which genes are turned on or off—from newly diagnosed Type 1 diabetes patients during their first year after diagnosis. They looked at whether patterns in gene activity could predict how much C-peptide (a measure of remaining insulin production) would decline by year two.

The research built on earlier findings from an initial group of patients. This time, the team tested those same patterns in a separate group of 168 newly diagnosed individuals to see if the results held up. They then combined data from both groups to gain more statistical power.

The study validated the original findings: gene expression changes during the first year after diagnosis were indeed associated with how quickly insulin production declined. This suggests the pattern is real and reproducible, not a one-time observation.

Younger age at diagnosis emerged as a factor linked to faster disease progression. The team also found that changes in immune cell populations—specifically a relative decrease in neutrophils—were associated with more rapid progression of the disease.

These findings bring researchers closer to understanding the biological basis for why Type 1 diabetes progresses at different rates in different people. Identifying which genes and immune markers are involved could eventually help doctors better predict individual disease trajectories and may inform the development of new therapies.

However, this is foundational research. More work is needed to translate these discoveries into practical tools or treatments for patients.

Source: EBioMedicine. Evidence type: PubMed indexed literature. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.